Oncocross Co., Ltd. (KOSDAQ:382150)
South Korea · Delayed Price · Currency is KRW 12,330
+110 (0.90%)
Dec 10, 2025, 3:30 PM KST
Oncocross Market Cap
Oncocross has a market cap or net worth of 146.86 billion as of December 10, 2025.
Market Cap
146.86B
Enterprise Value
125.17B
Revenue
884.68M
Ranking
n/a
PE Ratio
n/a
Stock Price
12,330.00
Market Cap Chart
Since December 18, 2024, Oncocross's market cap has increased from 106.25B to 146.86B, an increase of 38.22%. That is a compound annual growth rate of 39.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 10, 2025 | 148.18B | 97.10% |
| Dec 30, 2024 | 75.18B | -29.24% |
| Dec 18, 2024 | 106.25B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8.76T |
| LigaChem Biosciences | 6.75T |
| Peptron | 6.65T |